Literature DB >> 27660895

Pro- and anti-inflammatory cytokines in cutaneous leishmaniasis: a review.

Nahid Maspi1, Amir Abdoli1, Fathemeh Ghaffarifar1.   

Abstract

Cutaneous leishmaniasis (CL) is caused by different species of the genus Leishmania. Pro- and anti-inflammatory cytokines play different roles in resistance/susceptibility and the immunopathogenesis of Leishmania infection. The balance and dynamic changes in cytokines may control or predict clinical outcome. T helper 1 (Th1) inflammatory cytokines (especially interferon-γ, tumor necrosis factor-α and interleukin-12) are the crucial factors in the initiation of protective immunity against L. major infection, whereas T helper 2 cytokines including IL-5, IL-4, and IL-13 facilitate the persistence of parasites by downregulating the Th1 immune response. On the other hand, aggravation of inflammatory reactions leads to collateral tissue damage and formation of ulcer. For this reason, immunity system such as T regulatory cells produce regulatory cytokines such as transforming growth factor-β and IL-10 to inhibit possible injures caused by increased inflammatory responses in infection site. In this article, we review the role of pro- and anti-inflammatory cytokines in the immunoprotection and immunopathology of CL.

Entities:  

Keywords:  Cutaneous leishmaniasis; Cytokine; Immunopathology; Immunoprotection; Leishmania

Mesh:

Substances:

Year:  2016        PMID: 27660895      PMCID: PMC5070640          DOI: 10.1080/20477724.2016.1232042

Source DB:  PubMed          Journal:  Pathog Glob Health        ISSN: 2047-7724            Impact factor:   2.894


  230 in total

1.  Cell mediated immunity in American cutaneous and mucosal leishmaniasis.

Authors:  E M Carvalho; W D Johnson; E Barreto; P D Marsden; J L Costa; S Reed; H Rocha
Journal:  J Immunol       Date:  1985-12       Impact factor: 5.422

2.  Neutrophils reduce the parasite burden in Leishmania (Leishmania) amazonensis-infected macrophages.

Authors:  Erico Vinícius de Souza Carmo; Simone Katz; Clara Lúcia Barbiéri
Journal:  PLoS One       Date:  2010-11-03       Impact factor: 3.240

3.  Evaluation of recombinant Leishmania polyprotein plus glucopyranosyl lipid A stable emulsion vaccines against sand fly-transmitted Leishmania major in C57BL/6 mice.

Authors:  Nathan C Peters; Sylvie Bertholet; Phillip G Lawyer; Melanie Charmoy; Audrey Romano; Flavia L Ribeiro-Gomes; Lisa W Stamper; David L Sacks
Journal:  J Immunol       Date:  2012-10-08       Impact factor: 5.422

4.  Interleukin-13 inhibits inducible nitric oxide synthase expression in human mesangial cells.

Authors:  M Saura; R Martínez-Dalmau; A Minty; D Pérez-Sala; S Lamas
Journal:  Biochem J       Date:  1996-01-15       Impact factor: 3.857

Review 5.  IL-22, not simply a Th17 cytokine.

Authors:  Sascha Rutz; Céline Eidenschenk; Wenjun Ouyang
Journal:  Immunol Rev       Date:  2013-03       Impact factor: 12.988

6.  An essential role for IL-13 in maintaining a non-healing response following Leishmania mexicana infection.

Authors:  James Alexander; Frank Brombacher; H Adrienne McGachy; Andrew N J McKenzie; William Walker; K Christine Carter
Journal:  Eur J Immunol       Date:  2002-10       Impact factor: 5.532

7.  Th1/Th2 immune responses are associated with active cutaneous leishmaniasis and clinical cure is associated with strong interferon-gamma production.

Authors:  Lúcio Roberto Castellano; Dalmo Correia Filho; Laurent Argiro; Helia Dessein; Aluízio Prata; Alain Dessein; Virmondes Rodrigues
Journal:  Hum Immunol       Date:  2009-01-20       Impact factor: 2.850

8.  Transgenic mice expressing high levels of soluble TNF-R1 fusion protein are protected from lethal septic shock and cerebral malaria, and are highly sensitive to Listeria monocytogenes and Leishmania major infections.

Authors:  I Garcia; Y Miyazaki; K Araki; M Araki; R Lucas; G E Grau; G Milon; Y Belkaid; C Montixi; W Lesslauer
Journal:  Eur J Immunol       Date:  1995-08       Impact factor: 5.532

Review 9.  Interleukin-4 and interleukin-13: their similarities and discrepancies.

Authors:  P Chomarat; J Banchereau
Journal:  Int Rev Immunol       Date:  1998       Impact factor: 5.311

10.  A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis.

Authors:  Caroline Sutton; Corinna Brereton; Brian Keogh; Kingston H G Mills; Ed C Lavelle
Journal:  J Exp Med       Date:  2006-07-03       Impact factor: 14.307

View more
  54 in total

1.  6,7-Dehydroroyleanone diterpene derived from Tetradenia riparia essential oil modulates IL-4/IL-12 release by macrophages that are infected with Leishmania amazonensis.

Authors:  Mariana de Souza Terron-Monich; Izabel Galhardo Demarchi; Pollyanna Rina Ferreira da Silva; Áquila Carolina Fernandes Herculano Ramos-Milaré; Zilda Cristiani Gazim; Thaís Gomes Verzignassi Silveira; Maria Valdrinez Campana Lonardoni
Journal:  Parasitol Res       Date:  2018-12-05       Impact factor: 2.289

2.  Hetero-Polysaccharides Secreted from Dunaliella salina Exhibit Immunomodulatory Activity Against Peripheral Blood Mononuclear Cells and RAW 264.7 Macrophages.

Authors:  Mehendi Goyal; Manoj Baranwal; Satyendra Kumar Pandey; Mondem Sudhakara Reddy
Journal:  Indian J Microbiol       Date:  2019-08-23       Impact factor: 2.461

3.  Impact of primary mouse macrophage cell types on Leishmania infection and in vitro drug susceptibility.

Authors:  M Van den Kerkhof; L Van Bockstal; J F Gielis; P Delputte; P Cos; L Maes; Guy Caljon; Sarah Hendrickx
Journal:  Parasitol Res       Date:  2018-08-23       Impact factor: 2.289

Review 4.  Leishmaniasis and Trace Element Alterations: a Systematic Review.

Authors:  Ali Taghipour; Amir Abdoli; Afifeh Ramezani; Ahmad Abolghazi; Mirza Ali Mofazzal Jahromi; Salar Maani; Seyede Manizhe Heidar Nejadi; Sima Rasti; Morteza Shams; Ezatollah Ghasemi
Journal:  Biol Trace Elem Res       Date:  2021-01-06       Impact factor: 3.738

5.  Differential Regulation of l-Arginine Metabolism through Arginase 1 during Infection with Leishmania mexicana Isolates Obtained from Patients with Localized and Diffuse Cutaneous Leishmaniasis.

Authors:  Arturo A Wilkins-Rodríguez; Armando Pérez-Torres; Alma R Escalona-Montaño; Laila Gutiérrez-Kobeh
Journal:  Infect Immun       Date:  2020-06-22       Impact factor: 3.441

6.  Leishmania-Derived Trimannose Modulates the Inflammatory Response To Significantly Reduce Leishmania major-Induced Lesions.

Authors:  Tara L Grinnage-Pulley; Daniel E K Kabotso; Chelsea L Rintelmann; Rajarshi Roychoudhury; Robert G Schaut; Angela J Toepp; Katherine N Gibson-Corley; Molly Parrish; Nicola L B Pohl; Christine A Petersen
Journal:  Infect Immun       Date:  2017-12-19       Impact factor: 3.441

7.  Immunopathological characterization of human cutaneous leishmaniasis lesions caused by Leishmania (Viannia) spp. in Amazonian Brazil.

Authors:  Cláudia Maria Castro Gomes; Maria Gloria Teixeira Sousa; Joyce Prieto Bezerra Menezes; Marliane Campos Batista; Ana Carolina Stocco Lima; Walter Belda; Daniel Bradshaw; Monica Elinor Alves Gama; Márcia Dalastra Laurenti; Fernando Tobias Silveira; Carlos Eduardo Pereira Corbett
Journal:  Parasitol Res       Date:  2017-02-21       Impact factor: 2.289

8.  Influence of genetic variants of gamma interferon, interleukins 10 and 12 on Visceral Leishmaniasis in an endemic area, Iran.

Authors:  Mehdi Kalani; Maral Choopanizadeh; Manoochehr Rasouli
Journal:  Pathog Glob Health       Date:  2019-01-15       Impact factor: 2.894

9.  The Effect of Naja naja oxiana Snake Venom Against Leishmania tropica Confirmed by Advanced Assays.

Authors:  Iraj Sharifi; Fatemeh Tabatabaie; Saeideh Nikpour; Mahshid Mostafavi; Razieh Tavakoli Oliaee; Fatemeh Sharifi; Zahra Babaei; Elham Jafari; Ehsan Salarkia; Delavar Shahbazzadeh
Journal:  Acta Parasitol       Date:  2020-11-06       Impact factor: 1.440

10.  Leishmania RNA Virus 1 (LRV-1) in Leishmania (Viannia) braziliensis Isolates from Peru: A Description of Demographic and Clinical Correlates.

Authors:  Ruwandi Kariyawasam; Rachel Lau; Braulio M Valencia; Alejandro Llanos-Cuentas; Andrea K Boggild
Journal:  Am J Trop Med Hyg       Date:  2020-02       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.